Broad Institute responds to Berkeley CRISPR patent appeal – BioNews
Boston Business Journal |
Broad Institute responds to Berkeley CRISPR patent appeal
BioNews This marks the latest development in ongoing dispute over the US patent for CRISPR/Cas9 between the University of California at Berkeley (UC), and the University of Vienna and Professor Emmanuelle Charpentier, against the Broad Institute of MIT and … Broad tells appeals court it led the way on gene-editing ‘revolution’Boston Business Journal |
|
Gene Therapy Hope
GenomeWeb Gene therapies have been getting a lot of notice lately, leading CNBC to ask a biotech investor what all the fuss is about. Novartis’ CAR-T cell therapy, Kymriah, became the first approved gene therapy in the US in August. The US Food and Drug … |